サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545567

アレイ装置の世界市場

Array Instruments

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アレイ装置の世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アレイ装置の世界市場は2030年までに27億米ドルに達する見込み

2023年に19億米ドルと推定されるアレイ装置の世界市場は、分析期間2023-2030年にCAGR 5.3%で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるDNAマイクロアレイ技術は、CAGR 5.4%を記録し、分析期間終了までに14億米ドルに達すると予測されます。タンパク質マイクロアレイ技術分野の成長率は、分析期間中CAGR 5.8%と推定されます。

米国市場は5億760万米ドルと推定、中国はCAGR 5.1％で成長予測

米国のアレイ装置市場は、2023年に5億760万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 5.1%で推移し、2030年には4億2,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.1%と4.1%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界のアレイ装置市場- 主要動向と促進要因のまとめ

アレイ装置はどのように生物医学調査に革命を起こしているのか？

アレイ装置は、複雑な生物学的データを分析する上でこれまでにない能力を提供し、生物医学研究の分野で不可欠なツールとなっています。DNAマイクロアレイ、タンパク質アレイ、組織アレイを含むこれらの機器により、研究者は何千もの遺伝子、タンパク質、その他の生体分子の発現を同時に調査することができます。アレイ装置のハイスループットな性質は、科学者のゲノミクス、プロテオミクス、個別化医療へのアプローチ方法を一変させ、より包括的で正確な分析を可能にしました。アレイ装置は、複数のバイオマーカーを同時に調査することを容易にすることで、がん研究、遺伝子疾患、医薬品開発などの分野における発見のペースを加速してきました。遺伝子発現パターンやタンパク質の相互作用を迅速かつ正確に評価する能力により、これらの機器は現代の研究室業務の要となり、疾病メカニズムや潜在的な治療標的の理解における大きな進歩につながっています。

アレイ装置の能力を高める技術革新とは？

アレイ装置の進化は、その機能と応用範囲を拡大する絶え間ない技術革新によって推進されてきました。最近のマイクロアレイ技術の進歩は、これらの装置の感度、特異性、解像度を向上させ、遺伝子やタンパク質の発現の微細な変化も検出できるようになりました。さらに、高度な計算ツールの統合によってデータ解析能力が向上し、研究者は複雑なデータセットをより正確かつ効率的に解釈できるようになった。高密度アレイの開発など、アレイ設計における革新は、これらの装置のスループットをさらに向上させ、かつてないほど強力なものとなった。さらに、複数の種類の生体分子を同時に分析できる多重化アレイの出現は、特にシステム生物学の分野において、研究の新たな道を開いた。このような技術の進歩は、アレイ装置の性能を向上させただけでなく、その応用範囲を広げ、基礎科学から臨床診断まで、幅広い研究分野で必要不可欠なものとなっています。

なぜアレイ装置は個別化医療や診断において重要なのか？

アレイ装置は、精度と正確さが最も重要である個別化医療と診断学の進歩において、極めて重要な役割を果たしています。アレイ装置は、個々の患者の詳細な分子プロファイルを提供することができるため、病気の診断と治療の方法に革命をもたらしました。個別化医療では、アレイ装置は特定の治療に対する患者の反応を予測できる特定の遺伝子変異や発現パターンを同定するために使用され、よりオーダーメイドで効果的な治療戦略を可能にします。診断では、がん、心血管疾患、自己免疫疾患などの疾患の有無や進行を示すバイオマーカーの検出が可能になります。臨床現場におけるアレイ装置の採用は、画一的な治療から個別化治療への移行を促進し、患者の転帰を改善し、ヘルスケアコストを削減します。個別化されたヘルスケアソリューションへの需要が拡大し続ける中、研究と臨床の両面でアレイ装置の重要性が大幅に高まることが予想されます。

アレイ装置市場の成長の原動力は？

アレイ装置市場の成長は、その拡大と進化を形作るいくつかの要因によって牽引されています。主要な原動力は、大規模なデータセットを迅速かつ正確に分析する必要がある生物医学研究におけるハイスループット技術への需要の高まりです。また、個別化医療の台頭も市場の成長に大きく寄与しています。ヘルスケアプロバイダーが分子診断やオーダーメイド治療戦略のための高度なツールを求めているからです。次世代マイクロアレイの開発や、データ解析におけるAIと機械学習の統合などの技術的進歩は、これらの機器の機能と効率を高めることにより、市場をさらに促進しています。がん研究、医薬品開発、農業バイオテクノロジーなどの分野におけるアレイ装置の応用拡大が、市場成長の新たな機会を生み出しています。さらに、疾病の早期発見や精密医療の発展が重視されるようになり、特に医療インフラの整った先進諸国では、臨床診断におけるアレイ装置の採用が進んでいます。このような動向が進化を続ける中、アレイ装置市場は、イノベーションと、研究とヘルスケアの両分野における高度な分析ツールに対するニーズの拡大により、持続的な成長を遂げる態勢が整っています。

調査対象企業の例（全43件）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings（LabCorp）
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10375

Global Array Instruments Market to Reach US$2.7 Billion by 2030

The global market for Array Instruments estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. DNA Microarrays Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Protein Microarrays Technology segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.6 Million While China is Forecast to Grow at 5.1% CAGR

The Array Instruments market in the U.S. is estimated at US$507.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$422.7 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Array Instruments Market - Key Trends and Drivers Summarized

How Are Array Instruments Revolutionizing Biomedical Research?

Array instruments have become indispensable tools in the field of biomedical research, offering unprecedented capabilities in analyzing complex biological data. These instruments, which include DNA microarrays, protein arrays, and tissue arrays, enable researchers to study the expression of thousands of genes, proteins, or other biomolecules simultaneously. The high-throughput nature of array instruments has transformed the way scientists approach genomics, proteomics, and personalized medicine, allowing for more comprehensive and precise analyses. By facilitating the simultaneous examination of multiple biomarkers, array instruments have accelerated the pace of discovery in areas such as cancer research, genetic disorders, and drug development. The ability to quickly and accurately assess gene expression patterns and protein interactions has made these instruments a cornerstone of modern laboratory practices, leading to significant advancements in our understanding of disease mechanisms and potential therapeutic targets.

What Technological Innovations Are Enhancing the Capabilities of Array Instruments?

The evolution of array instruments has been driven by continuous technological innovations that have expanded their functionality and application scope. Recent advancements in microarray technology have increased the sensitivity, specificity, and resolution of these instruments, enabling the detection of even minute changes in gene or protein expression. Additionally, the integration of advanced computational tools has enhanced data analysis capabilities, allowing researchers to interpret complex datasets with greater accuracy and efficiency. Innovations in array design, such as the development of high-density arrays, have further increased the throughput of these instruments, making them more powerful than ever before. Moreover, the emergence of multiplexed arrays, which can analyze multiple types of biomolecules simultaneously, has opened new avenues for research, particularly in the field of systems biology. These technological strides have not only improved the performance of array instruments but have also broadened their applicability, making them essential in a wide range of research areas, from basic science to clinical diagnostics.

Why Are Array Instruments Critical in Personalized Medicine and Diagnostics?

Array instruments play a pivotal role in the advancement of personalized medicine and diagnostics, where precision and accuracy are paramount. The ability of these instruments to provide detailed molecular profiles of individual patients has revolutionized the way diseases are diagnosed and treated. In personalized medicine, array instruments are used to identify specific genetic mutations or expression patterns that can predict a patient’s response to certain therapies, allowing for more tailored and effective treatment strategies. In diagnostics, these instruments enable the detection of biomarkers that can indicate the presence or progression of diseases such as cancer, cardiovascular conditions, and autoimmune disorders. The adoption of array instruments in clinical settings has facilitated the transition from one-size-fits-all treatment approaches to more individualized care, improving patient outcomes and reducing healthcare costs. As the demand for personalized healthcare solutions continues to grow, the importance of array instruments in both research and clinical practice is expected to increase significantly.

What Is Driving the Growth of the Array Instruments Market?

The growth in the array instruments market is driven by several factors that are shaping its expansion and evolution. A key driver is the increasing demand for high-throughput technologies in biomedical research, where the need to analyze large datasets quickly and accurately is paramount. The rise of personalized medicine has also significantly contributed to market growth, as healthcare providers seek advanced tools for molecular diagnostics and tailored treatment strategies. Technological advancements, such as the development of next-generation microarrays and the integration of AI and machine learning in data analysis, are further propelling the market by enhancing the capabilities and efficiency of these instruments. The expanding application of array instruments in areas such as cancer research, drug development, and agricultural biotechnology is creating new opportunities for market growth. Additionally, the growing emphasis on early disease detection and the development of precision medicine are driving the adoption of array instruments in clinical diagnostics, particularly in developed countries with advanced healthcare infrastructures. As these trends continue to evolve, the array instruments market is poised for sustained growth, driven by innovation and the expanding need for sophisticated analytical tools in both research and healthcare.

Select Competitors (Total 43 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Array Instruments - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Technologies Spurs Growth of Array Instruments
    • Technological Advancements in Microarray Design Expands Addressable Market Opportunity
    • Increasing Application in Cancer Research Propels Growth in Array Instruments Market
    • Advancements in Multiplexed Arrays Generate Opportunities for Systems Biology Research
    • Growing Focus on Early Disease Detection Throws the Spotlight on Clinical Diagnostics
    • Expansion of Genomic Research Drives Adoption of Next-Generation Microarrays
    • Growing Need for Comprehensive Biomarker Analysis Drives Innovation in Array Technologies
    • Increased Use of Arrays in Agricultural Biotechnology Expands Application Scope
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Clinical Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Array Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION